These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3913641)

  • 1. BALB/c 3T3 cell transformation: protocols, problems and improvements.
    Schechtman LM
    IARC Sci Publ; 1985; 67():165-84. PubMed ID: 3913641
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens.
    Yasutake C; Kuratomi Y; Ono M; Masumi S; Kuwano M
    Cancer Res; 1987 Sep; 47(18):4894-9. PubMed ID: 2441855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for experimental protocols and for scoring transformed foci in BALB/c 3T3 and C3H 10T1/2 cell transformation.
    IARC Sci Publ; 1985; 67():205-19. PubMed ID: 3830890
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitation of chemically induced neoplastic transformation of BALB-3T3 cloned cell lines.
    DiPaolo JA; Takano K; Popescu NC
    Cancer Res; 1972 Dec; 32(12):2686-95. PubMed ID: 4674680
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
    Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
    Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to neoplastic transformation induced by nonterminal differentiation.
    Estervig DN; Maercklein PB; Scott RE
    Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters affecting the relationships among cytotoxic, genotoxic, mutational, and transformational responses in BALB/3T3 cells.
    Saffiotti U; Bignami M; Kaighn ME
    Carcinog Compr Surv; 1985; 9():139-51. PubMed ID: 4053070
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line.
    Bignami M; Ficorella C; Dogliotti E; Norman RL; Kaighn ME; Saffiotti U
    Cancer Res; 1984 Jun; 44(6):2452-7. PubMed ID: 6722787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical transformation in C3H 10T1/2 Cl 8 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol.
    Landolph JR
    IARC Sci Publ; 1985; 67():185-203. PubMed ID: 3913642
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of sensitivity to arsenic compounds between a Bhas 42 cell transformation assay and a BALB/c 3T3 cell transformation assay.
    Muramatsu D; Sasaki K; Kuroda S; Hayashi K; Tanaka N; Sakai A
    Mutat Res; 2009 Apr; 675(1-2):66-70. PubMed ID: 19386250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular communication capacity as a possible determinant of transformation sensitivity of BALB/c 3T3 clonal cells.
    Yamasaki H; Enomoto T; Shiba Y; Kanno Y; Kakunaga T
    Cancer Res; 1985 Feb; 45(2):637-41. PubMed ID: 3967239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plate-induced tumors of BALB/3T3 cells exhibiting foci of differentiation into pericytes, chondrocytes, and fibroblasts.
    Boone CW; Scott RE
    J Supramol Struct; 1980; 14(2):233-40. PubMed ID: 7230806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation.
    Komori A; Yatsunami J; Suganuma M; Okabe S; Abe S; Sakai A; Sasaki K; Fujiki H
    Cancer Res; 1993 May; 53(9):1982-5. PubMed ID: 8481899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rodent hepatocytes for metabolic activation in transformation assays.
    Sivak A; Tu AS
    IARC Sci Publ; 1985; 67():121-35. PubMed ID: 3830889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on cell malignant transformation caused by dihydroxyglyoxime].
    Shen J; Jiang Y; Zhang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Nov; 31(6):346-8. PubMed ID: 9863068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preneoplastic potential of morphologically distinct transformed foci induced by 3-methylcholanthrene.
    Keshava N; Keshava C; Whong WZ; Hubbs AF; Nath J; Ong T
    Environ Mol Mutagen; 1998; 32(4):369-76. PubMed ID: 9882012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between in-vitro cell transformation and in-vivo carcinogenesis based on available data on the effects of chemicals.
    Kuroki T; Sasaki K
    IARC Sci Publ; 1985; 67():93-118. PubMed ID: 3913647
    [No Abstract]   [Full Text] [Related]  

  • 18. Similarities in the formation and removal of covalent DNA adducts in benzo(a)pyrene-treated BALB/3T3 variant cells with different induced transformation frequencies.
    Lo KY; Kakunaga T
    Cancer Res; 1982 Jul; 42(7):2644-50. PubMed ID: 6282445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the uptake of 2-deoxy-D-glucose in BALB-3T3 cells chemically transformed in culture.
    Oshiro Y; DiPaolo JA
    J Cell Physiol; 1974 Apr; 83(2):193-201. PubMed ID: 4822526
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of TFX (Polfa) on mouse fibroblasts and macrophages in carcinogenicity assays.
    Duś D; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):731-7. PubMed ID: 6675574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.